biopharmaceutical research News
-
The leading pharmaceutical network in Europe
Polepharma, the network promoting excellence and innovation in the pharmaceutical and biopharmaceutical sectors, brings together research laboratories, production sites, contractors and training centers. To celebrate the 20th anniversary of this economic and industrial network, Polepharma has published a directory presenting its 370 members. Indatech – Chauvin Arnoux Group is one of those ...
-
Glyco-engineered Mammalian Cell Expression System Released at CD BioGlyco
CD BioGlyco, a biotechnology company that provides a full range of glycobiology-related products, analysis, custom synthesis, and design to help advance glycobiology research, recently released a glyco-engineered mammalian cell expression system to help scientists with their research. New biotherapeutic glycoproteins, such as recombinant monoclonal antibodies (mAbs), have been widely used to ...
By CD BioGlyco.
-
MerLion Pharmaceuticals Completes Growth Financing Round
MerLion Pharmaceuticals GmbH (MerLion), a biopharmaceutical company focused on research and development of novel antibiotics for the treatment of serious bacterial infections, today announced the successful completion of a growth financing round raised via a private placement to European strategic investors. The funds raised will primarily be used to finance the production and market launch of ...
-
CD Bioparticles Launches Locust Bean Gum for Biopharmaceutical Applications
CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, has launched a new line of Locust Bean Gum with advanced technical platforms to help scientists advance biopharmaceutical research. Over the past few decades, researchers have been working on developing delivery systems that can reduce side effects while improving efficacy. Natural polymers are ...
-
Amgen and Takeda join the Quantum Leap Project Led by Cqdm and Feldan Therapeutics, to Improve a Novel Intracellular Delivery Technology
CQDM is pleased to announce that following their recent enrollment in the consortium, Amgen and Takeda will be joining the syndicate of pharma companies to fund the Quantum Leap project recently launched by Feldan Therapeutics (Feldan). Amgen and Takeda will be contributing to this research project marking their first involvement in a CQDM-funded project since joining the consortium in 2018. The ...
-
Overview Article on Biotech and Medical Applications
After several years of intense research in close collaboration international partners from both, medical research and biopharmaceutical companies, Ionimed Analytik has released an overview articel, summarizing this work. This technical article Applications of PTR-MS in Medicine and Biotechnology has been published in American Laboratory (Tuesday, June 14, 2011) and is available online via this ...
-
CBD May Slow Cancer Growth
According to the American Cancer Society, scientists have recently reported that THC and other cannabinoids such as CBD slow growth and/or cause death in certain types of cancer cells growing in lab dishes. This is not only fascinating, but encouraging news for not only researchers, but those who are diagnosed with cancer, or have a loved one who has cancer. Additionally, some animal studies ...
-
Inspire Medical Systems, Inc. Announces Appointment of Bryan Phillips as General Counsel
Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea (“OSA”), announced today the appointment of Bryan Phillips as Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary. ...
-
The Importance of DNA Sequencing and Cancer Research
In the simplest of terms, DNA, or deoxyribonucleic acid, is the genetic code that determines all the characteristics of a living thing. This double, long chain of molecules called nucleotides tell each cell what proteins to make, giving them the genetic instruction guide for life and its processes. Each cell’s development, reproduction and death are controlled by the ...
-
PDA Announces the Jette Christensen Early Career Professional Grant in Memory of Past PDA Chair
PDA today announced the establishment of the Jette Christensen Early Career Professional Grant in memory of the Immediate-Past Chair of the PDA Board of Directors, who passed away on October 24 after a long battle with cancer. As a PDA member, Board Member, and PDA Chair, Jette’s dedication to PDA’s mission of advancing pharmaceutical/biopharmaceutical manufacturing science and ...
-
New AI-Enabled Virtual Screening Tool Identifies Most Promising Approved Drugs for Success in Treating COVID-19
WorldQuant Predictive (WQP), an AI predictive products company, and CAS, a division of the American Chemical Society that specializes in scientific information solutions, have partnered to develop a groundbreaking methodology that can save time and lives by helping research teams rapidly prioritize the most promising drug candidates to treat COVID-19 and other critical diseases. The scientific ...
-
Cannabis Sequencing and New Cancer Research
In 2014, the entire genome of Cannabis stavia L. was sequenced. This news received national attention with eye-catching headlines such as: “Marijuana Genome Sequenced for Health, Not Highs”. Researchers and oncologists took note, not due to the attention-grabbing headlines, but because their focus was to pair the decoded cannabis genome research with sequencing of the ...
-
Engineering antibody-antigen interfaces to improve therapeutic properties
Antibodies (immunoglobulins) are a key component of the mammalian immune response and are increasingly of interest as a means of therapy for several diseases. In fact, there are over 100 monoclonal antibodies that have been approved as drugs1. Despite this apparent success, there are issues with biopharmaceutical antibody research and development – not least the cost of goods. Although it ...
-
Axial Therapeutics to Participate in a Fireside Chat Hosted by LifeSci Capital
Axial Therapeutics Inc., a biotechnology company dedicated to building a unique class of gut-targeted programs for neurodegenerative diseases and neurodevelopmental disorders, today announced that company management will participate in a fireside chat hosted by LifeSci Capital on Tuesday, November 17, 2020 at 1:00 PM ET. About Axial Therapeutics Axial Therapeutics is a clinical-stage, ...
-
Axial Biotherapeutics to Present at the H.C. Wainwright 22nd Annual Global Investment Conference
Axial Biotherapeutics, a biotechnology company dedicated to building a unique class of gut-targeted programs for neurodegenerative diseases and neurodevelopmental disorders, today announced that management will present at the H.C. Wainwright Annual Global Investment Conference on Tuesday, September 15, 2020 at 2:00 PM ET. About Axial Biotherapeutics Axial Biotherapeutics is a clinical stage ...
-
An Overview of Glioblastoma
It is estimated that more than 240,000 cases of brain and nervous system tumors are diagnosed each year around the world. The most common and most lethal of these cancerous tumors are glioblastoma (GBM). What is Glioblastoma? Glioblastoma is a type of glioma, which is a brain tumor that begins in the star-shaped glial cells that surround and support nerve cells in the brain. GBM is a Grade IV ...
-
CQDM to support a $1.1 million Immune Biosolutions’ research project
CQDM is pleased to announce the funding of a new $1.1 million research project in conjunction with financial contributions from lead industrial partner, Immune Biosolutions, and co-funding from: Cancer Research Society, Mitacs, Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke and TransferTech. The funds will be used by the Université de Sherbrooke’s Professors ...
-
BIO’s Dr. McMurry-Heath Warns Executive Order to “Cripple Small, Innovative Companies” Working to Eradicate COVID-19
Dr. Michelle McMurry-Heath, the president and CEO of the Biotechnology Innovation Organization (BIO), released a statement today warning that an executive order to adopt foreign price controls on certain prescription medicines could “cripple” companies working to eradicate COVID-19 and lead to less patient access to lifesaving treatments. Dr. McMurry-Heath raised these and other ...
-
Current Treatment Options and Research for Glioblastoma
Glioblastoma originates in the brain and typically does not spread to other parts of the body. It is a particularly difficult cancer to treat because tumors often overlap with healthy brain tissue making full surgical removal usually impossible. Treatments such as chemotherapy and radiation may slow the disease’s progression, but there is currently no cure. Glioblastoma Multiforme is the ...
-
Axial Therapeutics to Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference
Axial Therapeutics Inc., a biotechnology company dedicated to building a unique class of gut-targeted programs for neurodegenerative diseases and neurodevelopmental disorders, today announced that company management will present at the virtual Piper Sandler 32 nd Annual Healthcare Conference taking place November 30 – December 3, 2020. The presentation will be available for registered ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you